Literature DB >> 19404766

Retrospective analysis of clinical profile prognostic factors and outcomes of 19 patients of emphysematous pyelonephritis.

Ambar Khaira1, Ankur Gupta, Devendra S Rana, Ashwini Gupta, Anil Bhalla, Dinesh Khullar.   

Abstract

AIM: We aimed to study the clinical profile, prognostic factors, and the 6-month outcome of patients with emphysematous pyelonephritis (EPN)
METHODS: All patients admitted with a diagnosis of emphysematous pyelonephritis between January 2001 and July 2007 were included.
RESULTS: Overall 19 cases were diagnosed to have emphysematous pyelonephritis. There were 16 females and three males. Fourteen cases had type 2 diabetes mellitus. Fourteen cases had unilateral involvement and five had bilateral involvement. Eleven cases were classified as having class 1 or 2 disease and eight cases had class 3 and 4 disease. E. coli was the most common organism cultured (68.4%). Five cases underwent percutaneous drainage of the collecting system and three cases had nephrectomy of which 10.5% (two with advanced disease) expired. Shock at admission (p = 0.03), serum creatinine >5.0 mg/dl (p = 0.035) and DIC (p = 0.017) were independent poor prognostic factors. There was no difference in the prognosis between patients who had >or=2 or <2 poor prognostic factors (p = 0.16). However, prognosis was not related to disease class, unilateral vs. bilateral involvement, sepsis or the age of the patient. At 6 months, two patients were on maintenance hemodialysis.
CONCLUSIONS: In cases of EPN, shock, serum creatinine >5.0 mg/dl and DIC at admission are poor prognostic factors. Larger prospective studies are needed to confirm our findings.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19404766     DOI: 10.1007/s11255-009-9552-y

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  26 in total

1.  Emphysematous pyelonephritis.

Authors:  E H SCHULTZ; E H KLORFEIN
Journal:  J Urol       Date:  1962-06       Impact factor: 7.450

2.  Scrotal extension of emphysematous pyelonephritis.

Authors:  Pranjal Modi; Rajiv Goel; Sharad Dodia
Journal:  Int Urol Nephrol       Date:  2007       Impact factor: 2.370

Review 3.  Sustained low-efficiency dialysis.

Authors:  Ashita J Tolwani; Thomas S Wheeler; Keith M Wille
Journal:  Contrib Nephrol       Date:  2007       Impact factor: 1.580

Review 4.  Bilateral emphysematous pyelonephritis with autosomal-dominant polycystic kidney disease successfully treated by conservative method.

Authors:  H Shimizu; K Hariu; Y Kamiyama; H Tomomasa; T Iizumi; T Yazaki; T Umeda
Journal:  Urol Int       Date:  1999       Impact factor: 2.089

5.  Clinical characteristics of emphysematous pyelonephritis.

Authors:  H J Tang; C M Li; M Y Yen; Y S Chen; S R Wann; H H Lin; S S Lee; Y C Liu
Journal:  J Microbiol Immunol Infect       Date:  2001-06       Impact factor: 4.399

6.  Bilateral emphysematous pyelonephritis and emphysematous cystitis with autosomal-dominant polycystic kidney disease: is conservative management justified?

Authors:  Narayanaswamy Arun; Abdullatif Hussain; Madan Mohan Kapoor; Fawzi Abul
Journal:  Med Princ Pract       Date:  2007       Impact factor: 1.927

7.  Bilateral emphysematous pyelonephritis caused by Candida infection.

Authors:  T S Hildebrand; L Nibbe; U Frei; R Schindler
Journal:  Am J Kidney Dis       Date:  1999-02       Impact factor: 8.860

8.  Emphysematous pyelonephritis: a 15-year experience with 20 cases.

Authors:  A A Shokeir; M El-Azab; T Mohsen; T El-Diasty
Journal:  Urology       Date:  1997-03       Impact factor: 2.649

9.  Successful medical treatment of emphysematous pyelonephritis in a renal allograft recipient.

Authors:  K V Baliga; A S Narula; A Sharma; R Khanduja; M Manrai; J Debnath; A S Sandhu
Journal:  Ren Fail       Date:  2007       Impact factor: 2.606

Review 10.  Carbapenems versus other beta-lactams in treating severe infections in intensive care: a systematic review of randomised controlled trials.

Authors:  S J Edwards; M J Clarke; S Wordsworth; C E Emmas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-03-29       Impact factor: 3.267

View more
  20 in total

1.  Emphysematous pyelonephritis: Our experience in managing these cases.

Authors:  Fatih Uruc; Ozgur Haki Yuksel; Aytac Sahin; Ahmet Urkmez; Caglar Yildirim; Ayhan Verit
Journal:  Can Urol Assoc J       Date:  2015 Jul-Aug       Impact factor: 1.862

2.  Acute kidney injury from pyelonephritis in an elderly man: case report.

Authors:  Sayed Husain; Manaf Alroumoh; Prince Mohan; Gabriel El-Kass; Surya V Seshan; Marilyn Galler
Journal:  Int Urol Nephrol       Date:  2011-07-08       Impact factor: 2.370

3.  Deriving a management algorithm for emphysematous pyelonephritis: Can we rely on minimally invasive strategies or should we be opting for earlier nephrectomy?

Authors:  Eve Boakes; Deepak Batura
Journal:  Int Urol Nephrol       Date:  2017-09-20       Impact factor: 2.370

4.  Emphysematous pyelonephritis treatment strategies in correlation to the CT classification: have the current experience and prognosis changed?

Authors:  Mohamed Mohamed Elawdy; Yasser Osman; Rasha T Abouelkheir; Samer El-Halwagy; Bassam Awad; Mohsen El-Mekresh
Journal:  Int Urol Nephrol       Date:  2019-07-15       Impact factor: 2.370

Review 5.  Prevalence and Risk Factors of Mortality in Emphysematous Pyelonephritis Patients: A Meta-Analysis.

Authors:  Xuan Thai Ngo; Tuan Thanh Nguyen; Ryan W Dobbs; Minh Sam Thai; Duc Huy Vu; Le Quy Van Dinh; Khoa Quy; Hieu Trong Le; Tien-Dat Hoang; Hanh Thi Tuyet Ngo; Trinh Ngoc Khanh Van; Ho Yee Tiong; Huy Gia Vuong
Journal:  World J Surg       Date:  2022-07-08       Impact factor: 3.282

Review 6.  A systematic review and meta-analysis of risk factors and treatment choices in emphysematous pyelonephritis.

Authors:  Rajeev Desai; Deepak Batura
Journal:  Int Urol Nephrol       Date:  2022-02-01       Impact factor: 2.370

Review 7.  The impact of diabetes on the pathogenesis of sepsis.

Authors:  G C K W Koh; S J Peacock; T van der Poll; W J Wiersinga
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-30       Impact factor: 3.267

8.  Emphysematous pyelonephritis: Is nephrectomy warranted?

Authors:  Mada Alsharif; Abdullah Mohammedkhalil; Basim Alsaywid; Ali Alhazmy; Salahadin Lamy
Journal:  Urol Ann       Date:  2015 Oct-Dec

Review 9.  Emphysematous pyelonephritis: Time for a management plan with an evidence-based approach.

Authors:  Omar M Aboumarzouk; Owen Hughes; Krishna Narahari; Richard Coulthard; Howard Kynaston; Piotr Chlosta; Bhaskar Somani
Journal:  Arab J Urol       Date:  2013-11-19

10.  Emphysematous Pyelonephritis Caused by Citrobacter freundii in a Patient with Type 2 Diabetes and Neurogenic Bladder.

Authors:  Min Jeong Kim; Ji Sang Park; Hye Jin Lim; Jihye Jung; Dong Geum Shin; Ki-Deok Lee; Yoon Young Jung; Kyung Wan Min; Kyung-Ah Han
Journal:  Infect Chemother       Date:  2013-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.